Global assays of hemostasis

Current Opinion in Hematology

Volumn 21, Issue 5, 2014, Pages 395-403

  Brummel Ziedins, Kathleen E ^a   Wolberg, Alisa S ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

computational modeling; global assays; thrombin generation; thromboelastography; thrombogram

Indexed keywords

ANALYTIC METHOD; ARTICLE; ASSAY; BLOOD ANALYSIS; BLOOD CLOTTING; HEMOSTASIS; MATHEMATICAL MODEL; PRIORITY JOURNAL; THROMBIN TIME; THROMBOELASTOGRAPHY; HUMAN; METABOLISM;

FIBRIN; THROMBIN; THROMBOPLASTIN;

FIBRIN; HEMOSTASIS; HUMANS; THROMBIN; THROMBOPLASTIN;

EID: 84906085474     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000074     Document Type: Article

References (108)

1. Quick A, Stanley-Brown M, Bancroft F. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 1935; 190:501-511
2. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple onestage antihemophilic factor assy procedure. J Lab Clin Med 1953; 41:637-647
3. Owren PA, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 1951; 3:201-208
4. Crawley JT, Zanardelli S, Chion CK, Lane DA. The central role of thrombin in hemostasis. J Thromb Haemost 2007; 5 (Suppl 1):95-101
5. Mann KG, Orfeo T, Butenas S, et al. Blood coagulation dynamics in haemostasis. Hamostaseologie 2009; 29:7-16
6. Hemker HC, Beguin S. Phenotyping the clotting system. Thromb Haemost 2000; 84:747-751
7. Butenas S, Brummel KE, Branda RF, et al. Mechanism of factor VIIadependent coagulation in hemophilia blood. Blood 2002; 99:923-930
8. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15
9. Hron G, Kollars M, Binder BR, et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006; 296:397-402
10. Nair SC, Dargaud Y, Chitlur M, Srivastava A. Tests of global haemostasis and their applications in bleeding disorders. Haemophilia 2010; 16 (Suppl 5):85-92
11. Ten Cate H. Thrombin generation in clinical conditions. Thromb Res 2012; 129:367-370
12. Young G, Sorensen B, Dargaud Y, et al. Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: Current state of art and future perspectives. Blood 2013; 121:1944-1950
13. Coppens M, EikelboomJW,Gustafsson D, et al. Translational success stories: Development of direct thrombin inhibitors. Circ Res 2012; 111:920-929
14. Wells PS, Forgie MA, Rodger MA. Treatment of venous thromboembolism. JAMA 2014; 311:717-728
15. Brummel-Ziedins K. Models for thrombin generation and risk of disease. J Thromb Haemost 2013; 11 (Suppl 1):212-223
16. Danforth CM, Orfeo T, Everse SJ, et al. Defining the boundaries of normal thrombin generation: Investigations into hemostasis. PLoS One 2012; 7:e30385
17. Foley JH, Orfeo T, Undas A, et al. From principle to practice: Bridging the gap in patient profiling. PLoS One 2013; 8:e54728
18. Brummel-Ziedins KE, Everse SJ, Mann KG, Orfeo T. Modeling thrombin generation: Plasma composition based approach. J Thromb Thrombolysis 2014; 37:32-44
19. Macfarlane RG, Biggs R. A thrombin generation test; the application in haemophilia and thrombocytopenia. J Clin Pathol 1953; 6:3-8
20. Hemker HC, Wielders S, Kessels H, Beguin S. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70:617-624
21. Hemker HC, Giesen PL, Ramjee M, et al. The thrombogram: Monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000; 83:589-591
22. Dargaud Y, Lienhart A, Negrier C. Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery. Blood 2010; 116:5734-5737
23. Dargaud Y, Trzeciak MC, Bordet JC, et al. Use of calibrated automated thrombinography θ/- thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 2006; 96:562-567
24. Besser M, Baglin C, Luddington R, et al. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. J Thromb Haemost 2008; 6:1720-1725
25. Tripodi A, Legnani C, Chantarangkul V, et al. High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J ThrombHaemost 2008; 6:1327-1333
26. Dargaud Y, Luddington R, Gray E, et al. Effect of standardization and normalization on imprecision of calibrated automated thrombography: An international multicentre study. Br J Haematol 2007; 139:303-309
27. Lawrie AS, Gray E, Leeming D, et al. A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique. Br J Haematol 2003; 123:335-341
28. Dargaud Y, Luddington R, Gray E, et al. Standardisation of thrombin generation test: Which reference plasma for TGT?. An international multicentre study. Thromb Res 2010; 125:353-356
29. Dargaud Y, Wolberg AS, Luddington R, et al. Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: An international multicentre study. Thromb Res 2012; 130:929-934
30. Woodle SA, Shibeko AM, Lee TK, Ovanesov MV. Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma. Thromb Res 2013; 132:374-380
31. Subcommittee on Control of Anticoagulation of the SSCotI. Towards a recommendation for the standardization of the measurement of plateletdependent thrombin generation. J Thromb Haemost 2011; 9:1859-1861
32. Simpson ML,Goldenberg NA, Jacobson LJ, et al. Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults. Thromb Res 2011; 127:317-323
33. Matsumoto T, Nogami K, Shima M. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis. Thromb Haemost 2013; 110:761-768
34. Greene LA, Goldenberg NA, Simpson ML, et al. Use of global assays to understand clinical phenotype in congenital factor VII deficiency. Haemophilia 2013; 19:765-772
35. Campbell RA, Overmyer KA, Selzman CH, et al. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood 2009; 114:4886-4896
36. Ninivaggi M, Apitz-Castro R, Dargaud Y, et al. Whole-blood thrombin generation monitored with a calibrated automated thrombogram-based assay. Clin Chem 2012; 58:1252-1259
37. Marchetti M, Diani E, ten Cate H, Falanga A. Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography. Haematologica 2012; 97:1173-1180
38. Ollivier V, Wang J, Manly D, et al. Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res 2010; 125:90-96
39. Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contributions of monocyte- And platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J Thromb Haemost 2011; 9:2251-2261
40. Boknas N, Faxalv L, Lindahl TL, Ramstrom S. Contact activation: Important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents. J Thromb Haemost 2014; 12:515-518
41. Peyrou V, Lormeau JC, Herault JP, et al. Contribution of erythrocytes to thrombin generation in whole blood. Thromb Haemost 1999; 81:400-406
42. Horne MK 3rd, Cullinane AM, et al. The effect of red blood cells on thrombin generation. Br J Haematol 2006; 133:403-408
43. Whelihan MF, Zachary V, Orfeo T, Mann KG. Prothrombin activation in blood coagulation: The erythrocyte contribution to thrombin generation. Blood 2012; 120:3837-3845
44. Rugeri L, Quelin F, Chatard B, et al. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk. Haemophilia 2010; 16:771-777
45. Turitto VT, Weiss HJ. Red blood cells: Their dual role in thrombus formation. Science 1980; 207:541-543
46. McEvoy L, Williamson P, Schlegel RA. Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci U S A 1986; 83:3311-3315
47. Nobes PR, Carter AB. Reticulocyte counting using flow cytometry. J Clin Pathol 1990; 43:675-678
48. Connor J, Pak CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 1994; 269:2399-2404
49. Bratosin D, Mazurier J, Tissier JP, et al. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998; 80:173-195
50. Moyer MP, Tracy RP, Tracy PB, et al. Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes. Arterioscler Thromb Vasc Biol 1998; 18:458-465
51. Berckmans RJ, Nieuwland R, Boing AN, et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85:639-646
52. Mann KG, Whelihan MF, Butenas S, Orfeo T. Citrate anticoagulation and the dynamics of thrombin generation. J Thromb Haemost 2007; 5:2055-2061
53. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: New approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007; 2007:91-96
54. Hartert HS. Blood coagulation studies with thromboelastography, a new investigation method [in German]. Klin Wochenschr 1948; 26:577-583
55. Hartert HS. The physical and biological constants of thrombelastography. Biorheology 1962; 1:31-39
56. Rivard GE, Brummel-Ziedins KE, Mann KG, et al. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost 2005; 3:2039-2043
57. Favaloro EJ, Lippi G, Franchini M. Laboratory diagnostics in thrombosis and hemostasis: The past, the present, and the future. Semin Thromb Hemost 2008; 34:579-583
58. Chitlur M, Sorensen B, Rivard GE, et al. Standardization of thromboelastography: A report from the TEG-ROTEM working group. Haemophilia 2011; 17:532-537
59. Chitlur M. Challenges in the laboratory analyses of bleeding disorders. Thromb Res 2012; 130:1-6
60. Van Geffen M, Van Heerde WL. Global haemostasis assays, from bench to bedside. Thromb Res 2012; 129:681-687
61. Whiting D, DiNardo JA. TEG and ROTEM: Technology and clinical applications. Am J Hematol 2014; 89:228-232
62. Aleshnick M, Orfeo T, Brummel-Ziedins K, et al. Interchangeability of rotational elastographic instruments and reagents. J Trauma Acute Care Surg 2014; 76:107-113
63. Foley JH, Butenas S, Mann KG, Brummel-Ziedins KE. Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation. Anal Biochem 2012; 422:46-51
64. Sankarankutty A, Nascimento B, Teodoro Da Luz L, Rizoli S. TEG(R) and ROTEM(R) in trauma: Similar test but different results?. World J Emerg Surg 2012; 7 (Suppl 1):S3
65. Nagler M, Ten Cate H, Kathriner S, et al. Consistency of thromboelastometry analysis under scrutiny: Results of a systematic evaluation within and between analysers. Thromb Haemost 2014; 111:1161-1166
66. Quarterman C, Shaw M, Johnson I, Agarwal S. Intra- And inter-centre standardisation of thromboelastography (TEG). Anaesthesia 2014. [Epub ahead of print]
67. Madsen DE, Ingerslev J, Sidelmann JJ, et al. Intraoperative blood loss during orthognathic surgery is predicted by thromboelastography. J Oral Maxillofac Surg 2012; 70:e547-e552
68. Bolliger D, Tanaka KA. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev 2013; 27:213-220
69. Pekelharing J, Furck A, Banya W, et al. Comparison between thromboelastography and conventional coagulation tests after cardiopulmonary bypass surgery in the paediatric intensive care unit. Int J Lab Hematol 2013. [Epub ahead of print]
70. Sharma AD, Al-Achi A, Seccombe JF, et al. Does incorporation of thromboelastography improve bleeding prediction following adult cardiac surgery?. Blood Coagul Fibrinolysis 2014. [Epub ahead of print]
71. Krzanicki D, Sugavanam A, Mallett S. Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transpl 2013; 19:852-861
72. Muller MC, Meijers JC, Vroom MB, Juffermans NP. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: A systematic review. Crit Care 2014; 18:R30. [Epub ahead of print]
73. Johansson PI, Stensballe J, Ostrowski SR. Current management of massive hemorrhage in trauma. Scand J Trauma Resusc Emerg Med 2012; 20:47
74. Raza I,Davenport R,Rourke C, et al. The incidence andmagnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11:307-314
75. Da Luz LT, Nascimento B, Rizoli S. Thrombelastography (TEG(R)): Practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med 2013; 21:29
76. Akay OM, Karagulle M, Kus G, et al. Thrombelastographic evaluation of the influence of 2-RBC apheresis on donor's coagulation system. Transfus Apher Sci 2013; 48:387-390
77. Van Haren RM, Thorson CM, Valle EJ, et al. Hypercoagulability after burn injury. J Trauma Acute Care Surg 2013; 75:37-43; discussion 43
78. Brazzel C. Thromboelastography-guided transfusion therapy in the trauma patient. AANA J 2013; 81:127-132
79. Chapman BC, Moore EE, Barnett C, et al. Hypercoagulability following blunt solid abdominal organ injury: When to initiate anticoagulation. Am J Surg 2013; 206:917-922
80. Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: Monitoring with thromboelastography, laboratory analyses or both?. Int J Obstet Anesth 2014; 23:10-17
81. Peng HT, Rhind SG. Thromboelastographic study of psychophysiological stress: A review. Clin Appl Thromb Hemost 2013. [Epub ahead of print]
82. Walenga JM, Jeske WP, Escalante V, et al. Thromboelastographic evaluation of blood coagulation in the presence of branded and generic enoxaparins. Int Angiol 2012; 31:517-525
83. Bowry R, Fraser S, Archeval-Lao JM, et al. Thrombelastography detects the anticoagulant effect of rivaroxaban in patients with stroke. Stroke 2014; 45:880-883
84. Chapman MP,Moore EE, Ramos CR, et al. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy. J Trauma Acute Care Surg 2013; 75:961-967; discussion 967
85. Siller-Matula JM, Trenk D, Schror K, et al. Response variability to P2Y12 receptor inhibitors: Expectations and reality. JACC Cardiovasc Interv 2013; 6:1111-1128
86. Weitzel NS, Weitzel LB, Epperson LE, et al. Platelet mapping as part of modified thromboelastography (TEG(R)) in patients undergoing cardiac surgery and cardiopulmonary bypass. Anaesthesia 2012; 67:1158-1165
87. Idorn L, Jensen AS, Juul K, et al. Thromboembolic complications in Fontan patients: Population-based prevalence and exploration of the etiology. Pediatr Cardiol 2013; 34:262-272
88. Al Hawaj MA, Martin EJ, Venitz J, et al. Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 2013; 19:409-414
89. Knappe S, Gorczyca ME, Jilma B, et al. Plasmatic tissue factor pathway inhibitor is a major determinant of clotting in factor VIII inhibited plasma or blood. Thromb Haemost 2013; 109:450-457
90. Mari D, Mannucci PM, Coppola R, et al. Hypercoagulability in centenarians: The paradox of successful aging. Blood 1995; 85:3144-3149
91. Sagripanti A, Carpi A. Natural anticoagulants, aging, and thromboembolism. Exp Gerontol 1998; 33:891-896
92. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16:153-168
93. Holmes VA, Wallace JM. Haemostasis in normal pregnancy: A balancing act?. Biochem Soc Trans 2005; 33:428-432
94. O'Donnell J, Mumford AD, Manning RA, Laffan MA. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. Br J Haematol 2001; 115:687-691
95. Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro- vs anticoagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009; 137:2105-2111
96. Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002; 277:18322-18333
97. Panteleev MA, Ovanesov MV, Kireev DA, et al. Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J 2006; 90:1489-1500
98. Luan D, Zai M, Varner JD. Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies. PLoS Comput Biol 2007; 3:e142
99. Anand M, Rajagopal K, Rajagopal KR. A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency. J Theor Biol 2008; 253:725-738
100. Chatterjee MS, Denney WS, Jing H, Diamond SL. Systems biology of coagulation initiation: Kinetics of thrombin generation in resting and activated human blood. PLoS Comput Biol 2010; 6:e1000950
101. Mitrophanov AY, Reifman J. Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation. Thromb Res 2011; 128:381-390
102. Brummel-Ziedins KE, Orfeo T, Everse SJ, Mann KG. Blood coagulation and fibrinolysis. In: Greer JP, Arber DA, Glader B, List AF, Means Jr RT, Paraskevas F, Rodgers GM, editors. Wintrobe's clinical hematology, 13th ed Philadelphia: Lippincott Williams & Wilkins; 2014. pp. 428-497
103. Mann KG. Is there value in kinetic modeling of thrombin generation?. Yes. J Thromb Haemost 2012; 10:1463-1469
104. Hemker HC, Kerdelo S, Kremers RM. Is there value in kinetic modeling of thrombin generation?. No (unless..). J Thromb Haemost 2012; 10:1470-1477
105. Lo K, Denney WS, Diamond SL. Stochastic modeling of blood coagulation initiation. Pathophysiol Haemost Thromb 2005; 34:80-90
106. Danforth CM, Orfeo T, Mann KG, et al. The impact of uncertainty in a blood coagulation model. Math Med Biol 2009; 26:323-336
107. Wagenvoord R, Hemker PW, Hemker HC. The limits of simulation of the clotting system. J Thromb Haemost 2006; 4:1331-1338
108. Onasoga-Jarvis AA, Leiderman K, Fogelson AL, et al. The effect of factor VIII deficiencies and replacement and bypass therapies on thrombus formation under venous flow conditions in microfluidic and computational models. PLoS One 2013; 8:e78732.